A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2001
12/26/2001	CN1327851A Caspule for dispelling wind and detoxicating body
12/26/2001	CN1327838A Niantongbao capsule and its preparing process
12/26/2001	CN1327834A Oral liquid for removing endogenous heat
12/26/2001	CN1327828A Adhesive bandage able to relieve inflammation, astringe and grow muscle and its preparing process
12/26/2001	CN1327824A Quick-acting medicine for treating intractable rheumatism
12/26/2001	CN1327793A Pyrrolo-triazine and pyrimidine compounds
12/26/2001	CN1076624C Nasally administrable compositions
12/26/2001	CN1076607C Process for preparing pharmaceutical composition containing novel steroid esters
12/26/2001	CN1076606C Use of novel steroid esters for preparing medicaments flammatory and anti-allergic activity
12/26/2001	CA2350043A1 Novel melanocortin -4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate
12/25/2001	US6333402 For therapy and diagnosis
12/25/2001	US6333341 Tumor necrosis factor, antiinflammatory agents and analgesics
12/25/2001	US6333325 Method of treating cytokine mediated diseases or conditions
12/25/2001	US6333311 Has inflammatory and immune response functions such as regulation of monocyte colony stimulating factor synthesis, regulation of interleukin synthesis, activation of natural killer cell activity, inhibition of metastasis
12/25/2001	US6333044 For therapy of inflammation and pain of a traumatic or pathologic origin
12/25/2001	US6333035 Administering monoclonal antibody against a human t-cell leukemia virus-derived transcription activating factor p40tax-induced cell membrane glycoprotein of 34 kda (gp34) in an amount effective for treating rheumatoid arthritis
12/25/2001	US6333034 Administering anti-properdin agent effective to selectively inhibit formation of an alternative complement pathway activation product
12/20/2001	WO2001096586A1 Antisense modulation of c/ebp alpha expression
12/20/2001	WO2001096567A1 Novel g protein-coupled receptor protein and dna thereof
12/20/2001	WO2001096565A2 Binding agents: chimeric ligand/receptor proteins
12/20/2001	WO2001096553A1 Novel g protein-coupled receptor protein and dna thereof
12/20/2001	WO2001096547A2 Human kinases
12/20/2001	WO2001096546A2 Protein phosphatases
12/20/2001	WO2001096397A2 Cd154 variants and uses thereof
12/20/2001	WO2001096360A1 Antisense modulation of c/ebp beta expression
12/20/2001	WO2001096345A1 Tetrapyrroles
12/20/2001	WO2001096336A2 6,5-fused bicyclic heterocycles
12/20/2001	WO2001096331A1 Lactam inhibitors of factor xa and method
12/20/2001	WO2001096330A2 Thrombin receptor antagonists
12/20/2001	WO2001096323A1 Serine protease inhibitors
12/20/2001	WO2001096322A1 Diamino phenothiazine derivatives and composition comprising same
12/20/2001	WO2001096311A2 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases
12/20/2001	WO2001096305A1 Serine protease inhibitors
12/20/2001	WO2001096302A1 Piperidines for use as orexin receptor antagonists
12/20/2001	WO2001096299A2 Indole derivatives and their use as 15-lipoxygenase inhibitors
12/20/2001	WO2001096298A2 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
12/20/2001	WO2001096296A1 Serine protease inhibitors
12/20/2001	WO2001095945A2 Prodrug compounds cleavable by thimet oligopeptidase
12/20/2001	WO2001095943A2 Prodrug compounds with an oligopeptide having an isoleucine residue
12/20/2001	WO2001095932A1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR VIIa INHIBITOR
12/20/2001	WO2001095929A2 Interferon for treatment of multiple sclerosis
12/20/2001	WO2001095928A2 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion
12/20/2001	WO2001095926A1 Immunosuppressor agent derived from morbillivirus
12/20/2001	WO2001095925A1 Pharmaceutical anti-inflammatory aerosol formulation
12/20/2001	WO2001095921A1 Cytokine production inhibitors, agents for protecting and promoting liver function, anti-inflammatory agents, immunosuppressants, drugs, cosmetics, foods and food materials
12/20/2001	WO2001095912A1 COMPOSITIONS CONTROLLING RELEASE pH RANGE AND/OR SPEED
12/20/2001	WO2001095899A2 Pharmaceutical compositions comprising cannabidiol derivatives
12/20/2001	WO2001095898A1 Analgesic and anti-inflammatory compositions containing cox-2 inhibitors
12/20/2001	WO2001095885A1 Dry-powder pharmaceutical formulation for inhalation comprising alpha4-intergrin antagonist
12/20/2001	WO2001095882A1 Novel aqueous anti-inflammatory pharmaceutical formulation
12/20/2001	WO2001095881A1 Pharmaceutical anti-inflammatory aerosol formulation
12/20/2001	WO2001095880A1 Novel pharmaceutical formulation suitable for nebulisation
12/20/2001	WO2001095879A1 Novel aqueous anti-inflammatory pharmaceutical formulation
12/20/2001	WO2001095877A2 Porous celecoxib matrices and methods of manufacture thereof
12/20/2001	WO2001095859A2 Novel heterocyclic analogs of diphenylethylene compounds
12/20/2001	WO2001087838A8 Cyclohexane derivatives and their use as therapeutic agents
12/20/2001	WO2001059128A3 Novel elongase gene and method for producing multiple-unsaturated fatty acids
12/20/2001	WO2001058896A8 Benzoxazole derivatives as tnf and pde iv inhibitors
12/20/2001	WO2001055108A3 Use of spl a2 inhibitors for the treatment of inflammation
12/20/2001	WO2001049689A3 NOVEL SUBSTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM
12/20/2001	WO2001044207A3 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
12/20/2001	WO2001031016A3 Processed human chemokines phc-1 and phc-2
12/20/2001	WO2001013949A3 Medical preparation for treating arthrosis, arthritis and other rheumatic joint diseases
12/20/2001	WO2000072832A3 Novel use of 1-[4-(cyanoindol-3yl)butyl]-4-(carbamoyl-benzofuran-5yl)-piperazine and its physiologically acceptable salts
12/20/2001	US20010053844 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
12/20/2001	US20010053782 Pyrrolo[2,3-d]pyrimidine compounds
12/20/2001	US20010053363 Novel amphipathic aldehydes and their uses as adjuvants and immunoeffectors
12/20/2001	US20010053357 Peptide having an amino acid sequence corresponding to an amino acid sequence of a V-domain of a receptor for advanced glycation endproduct.
12/20/2001	US20010053351 Inhibition of GSK-3 beta
12/20/2001	DE10028402A1 New pyridinylamino-alkanoyl-glycyl-beta-alanine derivatives, are integrin inhibitors useful for treating, e.g. thrombosis, cardiac infarction, coronary heart disease, inflammation, tumors, osteoporosis or restenosis
12/20/2001	CA2413149A1 Prodrug compounds with isoleucine
12/20/2001	CA2413077A1 Interferon for treatment of multiple sclerosis
12/20/2001	CA2412979A1 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases
12/20/2001	CA2412623A1 Tetrapyrroles
12/20/2001	CA2412462A1 6,5-fused bicyclic heterocycles
12/20/2001	CA2412356A1 Immunosuppressor agent derived from morbillivirus
12/20/2001	CA2412216A1 Lactam inhibitors of factor xa and method
12/20/2001	CA2411962A1 Methods for regulating a cell-mediated immune response by blockinglymphocytic signals and by blocking lfa-1 mediated adhesion
12/20/2001	CA2411805A1 Serine protease inhibitors
12/20/2001	CA2411798A1 Serine protease inhibitors
12/20/2001	CA2411495A1 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
12/20/2001	CA2411472A1 Cd154 variants
12/20/2001	CA2411116A1 Indole derivatives and their use as 15-lipoxygenase inhibitors
12/20/2001	CA2410824A1 Diamino phenothiazine derivatives and composition comprising same
12/20/2001	CA2410610A1 Human kinases
12/20/2001	CA2410228A1 A combination product comprising melagatran and a factor viia inhibitor
12/20/2001	CA2410171A1 Novel heterocyclic analogs of diphenylethylene compounds and uses thereof
12/20/2001	CA2409315A1 Protein phosphatases
12/19/2001	EP1164145A2 Non-anticoagulant desulfated heparins as medicaments
12/19/2001	EP1163906A2 Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen
12/19/2001	EP1163373A1 Antisense modulation of cellular inhibitor of apoptosis-1 expression
12/19/2001	EP1163356A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
12/19/2001	EP1163334A1 Polynucleotide and deduced amino acid sequences from stromal cells
12/19/2001	EP1163332A1 48 human secreted proteins
12/19/2001	EP1163267A1 47 human secreted proteins
12/19/2001	EP1163263A1 Dalda analogs and their use
12/19/2001	EP1163262A1 Phenylalanine derivatives
12/19/2001	EP1163255A1 50 human secreted proteins
12/19/2001	EP1163239A1 Modified amino-acid amides as cgrp antagonists
12/19/2001	EP1163238A1 Chemokine recpetor binding heterocyclic compounds

1 ... 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 ... 1272